World Of Taxonomy
46287-030Level 3

ATORVALIQ (ATORVALIQ)

**Product type:** Human Prescription Drug

**Active ingredient:** ATORVASTATIN CALCIUM TRIHYDRATE

**Strength:** 20 mg/5mL

**Dosage form:** Suspension

**Route:** Oral

**Labeler:** CMP Pharma, Inc.

**Marketing category:** NDA (NDA213260)

**Pharmacologic class:** HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

GET/api/v1/systems/ndc_fda/nodes/46287-030
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.